Michael B. Bottorff

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

Impact of a Comprehensive Heart Failure Management Program on Hospital Readmission and Functional Status of Patients With Advanced Heart Failure

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure

Prevention of hospitalizations for heart failure with an interactive home monitoring program

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Treatment guidelines in heart failure

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

Variations in family physicians’ and cardiologists’ care for patients with heart failure

Optimizing therapy for complex or refractory heart failure: A management algorithm

National Trends in the Initial Hospitalization for Heart Failure

Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes

HFSA 2006 Comprehensive Heart Failure Practice Guideline: Introduction and Table of Contents

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Percutaneous Repair or Surgery for Mitral Regurgitation

Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995

Computerizing Guidelines to Improve Care and Patient Outcomes: The Example of Heart Failure

Gender Differences in 1-Year Survival and Quality of Life Among Patients Admitted With Congestive Heart Failure

Congestive heart failure hospitalizations and survival in California: Patterns according to race/ethnicity

Rehospitalizations among Patients in the Medicare Fee-for-Service Program

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors

Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice Guidelines 11This work was supported in part by unrestricted grants from Bristol-Myers Squibb Co., Princeton, New Jersey; Burroughs Wellcome Co., Research Triangle Park, North Carolina; Merck & Co., West Point, Pennsylvania; and the Department of Veterans Affairs Research Service.22All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California in San Francisco.

Cost-effectiveness Analysis in Clinical Practice

Improving Safety with Information Technology

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Comprehensive Discharge Planning and Home Follow-up of Hospitalized Elders

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Heart failure disease management: a critical review

Trends in Heart Failure Incidence and Survival in a Community-Based Population

Cardiac Resynchronization in Chronic Heart Failure

Myocarditis

The Management of Chronic Heart Failure

A Comprehensive Management System for Heart Failure Improves Clinical Outcomes and Reduces Medical Resource Utilization

Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure

Correlation of the agency for health care policy and research congestive heart failure admission guideline with mortality: Peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure

Transitional Care of Older Adults Hospitalized with Heart Failure: A Randomized, Controlled Trial

Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy

Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay

Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000

Appropriate prescribing in elderly people: how well can it be measured and optimised?

Effects of computerized guidelines for managing heart disease in primary care

Improving Primary Care for Patients With Chronic Illness

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Myocarditis

Improving Primary Care for Patients With Chronic Illness

Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure

Safety of Aggressive Lipid Management

Statin-Associated Myopathy

Use of echocardiography in the management of congestive heart failure in the community

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Predicting Mortality Among Patients Hospitalized for Heart Failure

A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure

Underutilisation of ACE Inhibitors in Patients with Congestive Heart Failure

Safety Considerations with Niacin Therapy

Biomarkers in Heart Failure

Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Myocarditis

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

N‐terminal probrain natriuretic peptide (NT‐proBNP) in the emergency diagnosis and in‐hospital monitoring of patients with dyspnoea and ventricular dysfunction

Practical recommendations for the use of ACE inhibitors, beta‐blockers and spironolactone in heart failure: putting guidelines into practice

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Chronic Heart Failure in the United States

Effects of Nurse Management on the Quality of Heart Failure Care in Minority Communities

Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure

Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure

Evaluating Quality of Care for Patients With Heart Failure

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis.

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril

Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline

Forecasting the Future of Cardiovascular Disease in the United States

A circadian gene expression atlas in mammals: Implications for biology and medicine

Contemporary Definitions and Classification of the Cardiomyopathies

Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods

mice: Multivariate Imputation by Chained Equations inR

Improving Guideline Adherence

CCORT/CCS quality indicators for congestive heart failure care.

Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation

HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Adsorption of salicylic acid onto polymeric adsorbents and activated charcoal

Part 8: Adult Advanced Cardiovascular Life Support

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

Long-term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitors

A clinician's guide to statin drug-drug interactions

Pharmacokinetic Optimisation of the Treatment of Embolic Disorders

Influence of Hypertonic Saline Solution Infusion on Defibrillation Efficacy

Statin Safety and Drug Interactions: Clinical Implications

Heart failure: Evaluation and care of patients with left ventricular systolic dysfunction